PHA 373 - Product Labeling L3

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/142

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:51 PM on 6/1/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

143 Terms

1
New cards

Label

Written, printed, or graphic information appearing on the immediate container of a drug product

2
New cards

Labeling

Information on the label, outside package, package inserts, patient package inserts, or pharmacy prescription labels

3
New cards

Adequate directions for use

Instructions written in layman's terms allowing safe and effective use of a drug

4
New cards

What separates OTC drugs from Rx-only drugs regarding labeling?

Adequate directions for use

5
New cards

Durham-Humphrey Amendment of 1951

Rx drugs do not require adequate directions for use if "Rx Only" appears on the label

6
New cards

OTC labeling requirement

Must contain sufficient information for a layperson to safely and effectively use the product

7
New cards

Misbranded

Something is wrong with the label

8
New cards

Adulterated

Something is wrong with the drug product itself

9
New cards

What happens if required labeling information is missing?

The product is considered misbranded

10
New cards

National Drug Code (NDC)

An 11-digit number that uniquely identifies a drug product

11
New cards

Do all OTC and prescription drugs require an NDC?

Yes

12
New cards

What are the three components of an NDC number?

Labeler code, Product code, Package code

13
New cards

Labeler code

5-digit code assigned by FDA identifying manufacturer, repackager, or distributor

14
New cards

Product code

4-digit code assigned by manufacturer identifying strength, dosage form, and formulation

15
New cards

Package code

Code assigned by manufacturer identifying package size and type

16
New cards

Who assigns the labeler code?

FDA

17
New cards

Who assigns the product code?

Manufacturer

18
New cards

Who assigns the package code?

Manufacturer

19
New cards

What does the labeler code identify?

Manufacturer, repackager, or distributor

20
New cards

What does the product code identify?

Strength, dosage form, and formulation

21
New cards

What does the package code identify?

Package size and type

22
New cards

Can leading zeros be omitted from an NDC?

Yes

23
New cards

GMP

Good Manufacturing Practice

24
New cards

Inactive ingredients are also called

Adjuvants

25
New cards

How should inactive ingredients be listed?

Alphabetically and separately from active ingredients

26
New cards

Examples of inactive ingredients

Fragrances and flavors

27
New cards

Can coloring agents be present in oral dosage forms?

Yes

28
New cards

Can coloring agents be present in topical dosage forms?

Yes

29
New cards

Can coloring agents be present in ophthalmic dosage forms?

No

30
New cards

Can coloring agents be present in parenteral dosage forms?

No

31
New cards

Why may inert gases be present in parenteral products?

For stability

32
New cards

Must inert gases be listed on the label?

No

33
New cards

Which four electrolytes may require labeling on oral OTC products?

Sodium, Calcium, Magnesium, Potassium

34
New cards

Why are electrolyte warnings included on OTC labels?

For patients with kidney disease or electrolyte-restricted diets

35
New cards

Electrolyte warning recommendation

Consult a physician before use

36
New cards

FD&C Yellow No. 5 (tartrazine) warning

May precipitate allergic reactions

37
New cards

Sulfite warning

May precipitate allergic reactions

38
New cards

Aspartame warning

Contains phenylalanine; notice required for phenylketonurics

39
New cards

Mineral oil warning

Use at bedtime only; avoid use in infants and pregnancy

40
New cards

Wintergreen oil warning

Products containing more than 5% methyl salicylate must warn misuse is dangerous and keep out of reach of children

41
New cards

Sodium phosphate warning

May not exceed 90 mL per OTC container

42
New cards

Isoproterenol inhalation warning

Do not exceed prescribed dose; contact physician if breathing difficulty persists

43
New cards

Acetophenetidine (Phenacetin) warning

May cause kidney damage if taken in large amounts or for long periods

44
New cards

Salicylate (Aspirin) warning

Associated with Reye's syndrome

45
New cards

Alcohol warning

Consult physician before use if consuming three or more alcoholic beverages daily

46
New cards

Which products require alcohol warnings?

Internal analgesics and antipyretics

(Acetaminophen, aspirin, ibuprofen, naproxen, ketoprofen, etc)

47
New cards

Examples of products requiring alcohol warnings

Acetaminophen, aspirin, ibuprofen, naproxen, ketoprofen

48
New cards

Ipecac syrup boxed warning

For emergency use to cause vomiting in poisoning; contact physician or poison center immediately

49
New cards

Ipecac syrup storage warning

Keep out of reach of children

50
New cards

When should ipecac not be used?

Corrosive poisonings, petroleum distillates, or strychnine poisoning

51
New cards

Usual dose of ipecac syrup

15 mL for patients older than 1 year

52
New cards

Maximum container size for ipecac syrup

1 ounce (30 mL)

53
New cards

Package Insert (PI)

Manufacturer information directed toward healthcare professionals

54
New cards

Who approves package insert information?

FDA

55
New cards

Required package insert sections

  1. Description of drug,

  2. clinical pharmacology,

  3. indications and usage, contraindications,

  4. warnings and precautions,

  5. adverse reactions,

  6. potential for abuse or dependence,

  7. symptoms and treatment of overdose,

  8. dosage and administration,

  9. available dosage forms,

  10. date of most recent revision, and

  11. recommended or usual dosing

56
New cards

Pregnancy section requirements

Dosing information, fetal risk information, and pregnancy registry information

57
New cards

Lactation section requirements

Amount of drug in breast milk and potential effects on child

58
New cards

Females and Males of Reproductive Potential section

Pregnancy testing, contraception, and infertility information

59
New cards

Black Box Warning

Strongest FDA warning indicating risk of death or serious injury

60
New cards

What is another name for a boxed warning?

Black box warning

61
New cards

Patient Package Insert (PPI)

Patient-directed drug information required for certain medications

62
New cards

When were PPIs first required for oral contraceptives?

1970

63
New cards

Why were PPIs required for oral contraceptives?

Increased popularity and lack of awareness of serious side effects

64
New cards

Medication Guide (MedGuide)

Patient information required for drugs with serious risks or important adherence requirements

65
New cards

When were Medication Guides introduced?

1996

66
New cards

When is a MedGuide required?

When patient labeling could prevent serious adverse effects, serious risks exist, or adherence is crucial for effectiveness

67
New cards

What are the three reasons a MedGuide may be required?

Prevent serious adverse effects, inform patients of serious risks, or improve adherence necessary for effectiveness

68
New cards

REMS

Risk Evaluation and Mitigation Strategies

69
New cards

Which law authorized REMS?

Food and Drug Administration Amendments Act of 2007

70
New cards

Purpose of REMS

Manage known or potential serious risks associated with a drug

71
New cards

What is the key concept of REMS?

A safety feature where access requirements become increasingly restrictive

72
New cards

REMS Level 1

Professional labeling and package insert

73
New cards

REMS Level 2

Medication Guide (MedGuide)

74
New cards

REMS Level 3

Communication Plan

75
New cards

REMS Level 4

Elements To Assure Safe Use (ETASU)

76
New cards

REMS Level 5

Implementation System

77
New cards

Which REMS level is least restrictive?

Professional labeling and package insert

78
New cards

Which REMS level is most restrictive?

Implementation System

79
New cards

What does ETASU stand for?

Elements To Assure Safe Use

80
New cards

REMS example

iPledge for isotretinoin

81
New cards

REMS example

STEPS for thalidomide

82
New cards

REMS example

Clozaril National Registry

83
New cards

REMS example

OxyContin REMS Educational Program

84
New cards

Which REMS programs require prescriber, patient, and pharmacy enrollment?

iPledge, STEPS, Clozaril National Registry, Rosiglitazone programs

85
New cards

Which REMS program requires only prescriber enrollment?

OxyContin REMS Educational Program

86
New cards

Identification requirement for solid dosage forms

Solid oral dosage forms must be imprinted

87
New cards

Which dosage forms require imprints?

Tablets, capsules, and gel caps

88
New cards

What information must an imprint identify?

Manufacturer and specific drug product

89
New cards

Which regulation requires imprinting?

Code of Federal Regulations (CFR)

90
New cards

What does CFR stand for?

Code of Federal Regulations

91
New cards

Which drug is exempt from imprint requirements?

Nitroglycerin

92
New cards

Why is nitroglycerin exempt?

Tablets are too small and unstable when exposed to air

93
New cards

Off-label use

Use of a drug for an indication not approved by the NDA

94
New cards

Can prescribers prescribe drugs off-label?

Yes

95
New cards

Can pharmacists dispense drugs off-label?

Yes

96
New cards

Can manufacturers advertise off-label uses?

No

97
New cards

Can manufacturers distribute peer-reviewed off-label information?

Yes, if requested by a healthcare professional

98
New cards

Purpose of bar coding

Reduce medication errors

99
New cards

Which products must manufacturers barcode?

All drug products supplied to hospitals

100
New cards

Must hospitals use barcodes?

No